Hajnalka Szaboki, Jonathan L. Kaufman, Shambavi Richard, Sebastian Grosicki, Istvan Takacs, Marc Raab, Cyrus Khandanpour, Andras Strassz, Andreas Pahl, Michael Kulke, Kristin Decker, Alexandra Braun, Thomas Philippi, Anette Last, Clemens Kruspel, Robert Orlowski, Frank Richard, Oliver Schonborn-Kellenberger, Throsten Lehr, Christiane Dings
{"title":"抗bcma抗体-药物偶联HDP-101与一种新的Amanitin有效载荷在复发/难治性多发性骨髓瘤的1/2a期临床试验中显示出有希望的数据,并进入队列7","authors":"Hajnalka Szaboki, Jonathan L. Kaufman, Shambavi Richard, Sebastian Grosicki, Istvan Takacs, Marc Raab, Cyrus Khandanpour, Andras Strassz, Andreas Pahl, Michael Kulke, Kristin Decker, Alexandra Braun, Thomas Philippi, Anette Last, Clemens Kruspel, Robert Orlowski, Frank Richard, Oliver Schonborn-Kellenberger, Throsten Lehr, Christiane Dings","doi":"10.1016/S2152-2650(25)03463-9","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Page S40"},"PeriodicalIF":2.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Anti-BCMA Antibody-Drug Conjugate HDP-101 with a Novel Amanitin Payload Shows Promising Data in Relapsed/Refractory Multiple Myeloma in a Phase 1/2a Clinical Trial as it Advances into Cohort 7\",\"authors\":\"Hajnalka Szaboki, Jonathan L. Kaufman, Shambavi Richard, Sebastian Grosicki, Istvan Takacs, Marc Raab, Cyrus Khandanpour, Andras Strassz, Andreas Pahl, Michael Kulke, Kristin Decker, Alexandra Braun, Thomas Philippi, Anette Last, Clemens Kruspel, Robert Orlowski, Frank Richard, Oliver Schonborn-Kellenberger, Throsten Lehr, Christiane Dings\",\"doi\":\"10.1016/S2152-2650(25)03463-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10348,\"journal\":{\"name\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"volume\":\"25 \",\"pages\":\"Page S40\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2152265025034639\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma, Myeloma & Leukemia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2152265025034639","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
The Anti-BCMA Antibody-Drug Conjugate HDP-101 with a Novel Amanitin Payload Shows Promising Data in Relapsed/Refractory Multiple Myeloma in a Phase 1/2a Clinical Trial as it Advances into Cohort 7
期刊介绍:
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.